In obese patients, the known decrease of circulating omentin levels is associated with endothelial dysfunction [300], while in patients with T2DM, increased circulating omentin levels are positively associated with the improvement of the endothelial function [301]. The gene discussed is ITLN1; the disease is type 2 diabetes mellitus.